Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Wilms Tumor 1Sarcoma 1Neoplasms 1Brain Neoplasms 1

Interventions

Filgrastim 10Cyclophosphamide 8X-Rays 6Phantoms, Imaging 6Granulocyte Colony-Stimulating Factor 6Temozolomide 5Specimen Handling 5Magnetic Resonance Spectroscopy 5Ifosfamide 5Carboplatin 5Vincristine 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Nuclear Medicine Department, Hospital 4Melphalan 4Etoposide 4Busulfan 4Topotecan 3Thiotepa 3Stem Cell Transplantation 3Mesna 3Cisplatin 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2sargramostim 2palbociclib 2olaparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × tariquidar × Sarcoma × Clear all
NCT00011414 2019-07-16

Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
29 enrolled
CNSGenitourinarySarcoma

Brain Neoplasms, Neoplasms, Wilms Tumor, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡